Yeah Gordon, this would seem like the most logical course to take. Group-approve multiple items if possible for a specific company and then move on to the next pending approval(s). Hopefully the FDA follows this course. As of now, they have my contempt at how "fast" they move on things but lets hope they redeem themselves in the coming weeks!
News 
Market Data 
Discover 
AI
